Assay of plasma samples representing different HIV-1 genetic subtypes: An evaluation of new versions of the Amplicor HIV-1 Monitor assay

AIDS Research and Human Retroviruses

Volumn 15, Issue 10, 1999, Pages 889-894

  Alaeus, Annette ^a   Lilja, Elisabet ^b   Herman, Steven ^c   Spadoro, Joanne ^c   Wang, June ^c   Albert, Jan ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD SAMPLING; GENETIC RISK; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SEROCONVERSION; VIRUS LOAD; VIRUS TRANSMISSION;

EVALUATION STUDIES; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; VARIATION (GENETICS); VIRAL LOAD;

EID: 0033168235     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310593     Document Type: Article

References (14)

1. Henrard DR, Phillips JF, Muenz LR, et al.: Natural history of HIV-1 cell-free viremia. JAMA 1995;274:554-558.
2. Mellors JW, Rinaldo CRJ, Gupta P, White RM, Todd JA, and Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
3. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-954.
4. + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-431.
5. Carpenter CC, Fischl MA, Hammer SM, et al.: Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society - USA panel. JAMA 1997;277: 1962-1969.
6. Centers for Disease Control and Prevention: Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR 1998;47(No. RR-5):1-49.
7. Alaeus A, Lidman K, Sönnerborg A, and Albert J: Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 1997;11:859-865.
8. Fang G, Burger H, Grimson R, et al.: Maternal plasma human immunodeficiency virus type 1 RNA level: A determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995;92:12100-12104.
9. Cao Y, Krogstad P, Korber BT, et al.: Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nature Med 1997;3:549-552.
10. Fiore JR, Zhang YJ, Bjorndal A, et al.: Biological correlates of HIV-1 heterosexual transmission. AIDS 1997;11:1089-1094.
11. Alaeus A, Leitner T, Lidman K, and Albert J: Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997;11:199-202.
12. + T-cell determinations in persons with human immunodeficiency (HIV) infections. MMWR 1994;43(RR-3): 1-21.
13. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993;41:1-19.
14. Dunne AL and Crowe SM: Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma. AIDS 1997;11:126-127.